David S. Rampton

David S. Rampton's AcademicInfluence.com Rankings

David S. Rampton

Philosophy

#9287

World Rank

#12825

Historical Rank

Logic

#6270

World Rank

#7775

Historical Rank

philosophy Degrees

Download Badge

Philosophy

David S. Rampton's Degrees

Doctorate Medicine Stanford University
PhD Biomedical Sciences Stanford University

Why Is David S. Rampton Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David S. Rampton's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs (2001) (541)
Psychological stress in IBD: new insights into pathogenic and therapeutic implications (2005) (538)
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. (2007) (452)
Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. (1994) (431)
Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? (1985) (366)
Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. (1992) (330)
Differential regulation of interleukin 17 and interferon γ production in inflammatory bowel disease (2009) (291)
Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. (1996) (271)
Molecular Characterization of Rectal Mucosa‐Associated Bacterial Flora in Inflammatory Bowel Disease (2005) (271)
Anti‐inflammatory effects of aloe vera gel in human colorectal mucosa in vitro (2004) (253)
Randomized, double‐blind, placebo‐controlled trial of oral aloe vera gel for active ulcerative colitis (2004) (243)
Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool (2004) (228)
Platelets circulate in an activated state in inflammatory bowel disease. (1994) (227)
Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management (2014) (218)
Mood disorders in inflammatory bowel disease: Relation to diagnosis, disease activity, perceived stress, and other factors (2012) (195)
Non-steroidal anti-inflammatory drugs and the lower gastrointestinal tract. (1987) (181)
Review article: complementary and alternative therapies for inflammatory bowel disease (2006) (175)
Inflammatory bowel disease--a radical view. (1993) (161)
Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. (1992) (157)
Analgesic ingestion and other factors preceding relapse in ulcerative colitis. (1983) (151)
Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies. (2007) (148)
Prostaglandins and ulcerative colitis. (1984) (147)
Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. (1994) (145)
Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs. (1981) (141)
Mucosal reactive oxygen metabolite production in duodenal ulcer disease. (1992) (139)
The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. (2006) (137)
Thrombosis and inflammatory bowel disease. (2005) (137)
Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease (2012) (131)
Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatment. (1981) (128)
Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis. (1980) (126)
High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. (1994) (122)
Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease (1991) (117)
Incidence of Inflammatory Bowel Disease is Rising and Abdominal Tuberculosis is Falling in Bangladeshis in East London, United Kingdom (2004) (116)
The Role of Psychological Stress in Inflammatory Bowel Disease (2007) (115)
Do Antidepressants Influence the Disease Course in Inflammatory Bowel Disease? A Retrospective Case‐Matched Observational Study (2012) (113)
Systematic review: Clostridium difficile and inflammatory bowel disease (2011) (112)
Use of Complementary Therapies by Patients with IBD May Indicate Psychosocial Distress (2002) (107)
Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper (2000) (105)
Diagnostic and therapeutic push type enteroscopy in clinical use. (1995) (104)
Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management (2015) (101)
Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial (2005) (100)
Review article: platelets in inflammatory bowel disease— pathogenetic role and therapeutic implications (1997) (98)
The Effect of Hypnosis on Systemic and Rectal Mucosal Measures of Inflammation in Ulcerative Colitis (2008) (96)
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease (2019) (95)
Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study (2002) (95)
Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease. (1995) (94)
Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system. (1999) (93)
Formation of Platelet-leukocyte Aggregates in Inflammatory Bowel Disease (2004) (89)
Blockade of transforming growth factor β upregulates T-box transcription factor T-bet, and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosa (2008) (83)
Molecular characterization of the bacteria adherent to human colorectal mucosa (2006) (81)
Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. (1997) (80)
Appendiceal inflammation in ulcerative colitis (1998) (79)
Platelet dysfunction: a new dimension in inflammatory bowel disease. (1995) (73)
Circulating von Willebrand factor in inflammatory bowel disease. (1992) (73)
Circulating antibodies to heat‐shock protein 60 in Crohn's disease and ulcerative colitis (1992) (73)
Optimizing quality of outpatient care for patients with inflammatory bowel disease: the importance of specialist clinics (2006) (72)
Does psychological counseling alter the natural history of inflammatory bowel disease? (2010) (70)
Factors associated with thiopurine non‐adherence in patients with inflammatory bowel disease (2013) (67)
SMOKING AND ULCERATIVE COLITIS (1984) (64)
Altered expression of cell adhesion molecules in uninvolved gut in inflammatory bowel disease (1993) (63)
Oral Iron Therapy in Inflammatory Bowel Disease: Usage, Tolerance, and Efficacy (2003) (62)
Diverticular colitis: diagnosis and management (2001) (59)
Integrated models of care in managing inflammatory bowel disease: a discussion. (2012) (59)
Thrornboxanes in inflammatory bowel disease—pathogenic and therapeutic implications (1993) (58)
Management of stress in inflammatory bowel disease: a therapeutic option? (2009) (54)
The Influence of Stress on the Development and Severity of Immune-Mediated Diseases (2011) (53)
Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability (1993) (50)
How can we improve models of care in inflammatory bowel disease? An international survey of IBD health professionals. (2014) (49)
Role of prostaglandins in bile salt-induced changes in rat colonic structure and function. (1981) (49)
Management of Crohn's disease (1999) (46)
Treatment of chronic renal failure with dietary fiber. (1984) (45)
Preventing TB in patients with Crohn’s disease needing infliximab or other anti-TNF therapy (2005) (45)
Helicobacter pylori, free radicals and gastroduodenal disease (1994) (43)
Effect of colonic perfusion with sulfated and nonsulfated bile acids on mucosal structure and function in the rat (1983) (43)
Nonspecific ulcerative colitis as a sequel to amebic dysentery. (1983) (40)
Psychological stress and coping in IBD (2008) (40)
Relationship between rectal mucosal prostaglandin production and water and electrolyte transport in ulcerative colitis. (1984) (39)
On the safety of intravenous iron, evidence trumps conjecture (2015) (38)
Efficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practice (2011) (36)
Low incidence of ulcerative colitis and proctitis in Bangladeshi migrants in Britain. (1992) (35)
Application of the who fracture risk assessment tool (FRAX) to predict need for dexa scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis (2011) (35)
Increased leukotriene B4 release from ileal pouch mucosa in ulcerative colitis compared with familial adenomatous polyposis. (1994) (34)
Poster presentations at medical conferences: an effective way of disseminating research? (2011) (34)
Review article: thromboxanes in inflammatory bowel disease--pathogenic and therapeutic implications. (1993) (34)
Platelet–leucocyte aggregates form in the mesenteric vasculature in patients with ulcerative colitis (2008) (33)
Does Stress Influence Inflammatory Bowel Disease? The Clinical Data (2010) (31)
Evaluation of new therapies for inflammatory bowel disease. (2003) (31)
Quantitative culture of Helicobacter pylori from gastric juice: the potential for transmission. (2000) (30)
Crohn's disease in Bangladeshis and Europeans in Britain: an epidemiological comparison in Tower Hamlets. (1992) (30)
Lack of efficacy of ridogrel, a thromboxane synthase inhibitor, in a placebo‐controlled, double‐blind, multi‐centre clinical trial in active Crohn’s disease (2001) (29)
The pro‐drug sulindac may reduce the risk of intestinal damage associated with the use of conventional non‐steroidal anti‐inflammatory drugs (1991) (28)
Is the rectum usually empty?—A quantitative study in subjects with and without diarrhea (1981) (27)
Epidemiology of inflammatory bowel disease in different ethnic and religious groups: limitations and aetiological clues (2004) (27)
Rectal mucosal histamine release in ulcerative colitis. (1980) (26)
The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descent (2012) (25)
Incidence of abdominal tuberculosis in Bangladeshi migrants in east London. (1993) (24)
“Diversion” Colitis Caused by Clostridium difficile Infection: Report of a Case (2006) (24)
Eicosanoids: role in gastrointestinal inflammation and cancer. (1997) (23)
Benoxaprofen in the treatment of active ulcerative colitis. (1983) (23)
Incidence and Outcome of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease in the UK (2017) (22)
Antibodies to human recombinant lipocortin-I in inflammatory bowel disease. (1993) (22)
Drug Interactions in Inflammatory Bowel Disease (2008) (22)
Oxalate loading test: a screening test for steatorrhoea. (1979) (22)
Factors Associated With Nonadherence to Thiopurines in Adolescent and Adult Patients With Inflammatory Bowel Disease (2012) (21)
Effect of colonic perfusion with sulfated and nonsulfated bile acids on mucosal structure and function in the rat. (1983) (21)
Treatment of iron deficiency anemia: practical considerations. (2015) (21)
Enteritis and colitis associated with mefenamic acid (1983) (20)
P0610 ENTERAL NUTRITION THERAPY IN CROHN???S DISEASE CHANGES THE MUCOSAL FLORA (2004) (19)
Methotrexate in Crohn's disease (2001) (18)
Rectal mucosal prostaglandin E release and electrolyte transport in ulcerative colitis. (1979) (18)
Fast Facts: Inflammatory Bowel Disease (2020) (18)
Anti-endothelial cell antibodies in inflammatory bowel disease (1993) (18)
Gut pH and transit time in ulcerative colitis appear sufficient for complete dissolution of pH-dependent 5-ASA-containing capsules (2000) (18)
Is microscopic colitis due to bile-salt malabsorption? (1987) (17)
Oral Iron Treatment Response and Predictors in Anaemic Adolescents and Adults with IBD: A Prospective Controlled Open-Label Trial (2016) (17)
Bile acid malabsorption in patients with graft‐versus‐host disease of the gastrointestinal tract (2012) (16)
The effects of pentobarbitone anaesthesia on the volume and composition of the extracellular fluid of dogs (1974) (16)
Thromboxane synthase immunohistochemistry in inflammatory bowel disease. (2002) (16)
Tobacco dependence and awareness of health risks of smoking in patients with inflammatory bowel disease (2011) (16)
Diversion colitis: a trigger for ulcerative colitis in the in-stream colon? (1999) (14)
Acute mesenteric infarction: an important cause of abdominal pain in ulcerative colitis. (2005) (12)
New flow cytometric technique for the evaluation of circulating endothelial progenitor cell levels in various disease groups. (2006) (11)
Recto‐urethral fistula in Crohn's disease (1982) (11)
Inflammatory bowel disease : clinical diagnosis and management (2000) (11)
Hypertensive crisis in a patient given sinemet, metoclopramide, and amitriptyline. (1977) (10)
The effects of the production of sodium depletion by peritoneal dialysis with 5% glucose on the volume and composition of the extracellular fluid of dogs (1974) (10)
New treatments for inflammatory bowel disease. (1998) (9)
Editorial: which iron preparation for patients with IBD? (2017) (8)
Crohn's disease recurrence can be prevented after ileal resection (2002) (8)
Screening for steatorrhoea with an oxalate loading test. (1984) (8)
Comparison of the effects of anaerobic and micro-aerophilic incubation on resistance of Helicobacter pylori to metronidazole. (1999) (8)
Enteric and Other Secondary Hyperoxalurias (1988) (8)
Are prostaglandins cytoprotective in the human large intestine?—the effect of indomethacin on rectal mucosal function and prostaglandin E2 releasein vivo (1984) (7)
Excess nitric oxide in ulcerative colitis may be generated by nitric oxide synthase independent pathways (1999) (7)
Verapanzil inhibits in‐vitro leucotriene B4 release by rectal mucosa in active ulcerative colitis (1992) (6)
Failure of allopurinol to modify urinary composition in enteric hyperoxaluria. (1989) (6)
Eicosanoid release by rectal mucosa in vitro in ulcerative colitis: effects of conventional and potential new therapies (1992) (6)
Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges (2011) (6)
Co-localisation of E. coli with macrophages in lamina propria in patient with active inflammatory bowel disease (IBD) (2003) (6)
Leucocytapheresis for ulcerative colitis. (2004) (6)
Inpatient diarrhoea and Clostridium difficile (2012) (5)
Herbs and Inflammatory Bowel Disease. (2017) (5)
Effects of indomethacin and misoprostol on renal function in healthy volunteers. (1992) (5)
Selenium supplementation in the diets of patients suffering from ulcerative colitis (1997) (5)
Increased health burden associated with Clostridium difficile diarrhoea in inflammatory bowel disease (2011) (5)
Inpatient diarrhoea and Clostridium difficile infection. (2012) (4)
The effect of disodium cromoglycate on rectal mucosal histamine release, eosinophil exudation and disease activity in active ulcerative colitis (1982) (4)
Clinical Dilemmas in Inflammatory Bowel Disease (2011) (4)
Verapamil inhibits in-vitro leucotriene B4 release by rectal mucosa in active ulcerative colitis. (1992) (4)
Anxiety and psychological stress in acute severe ulcerative colitis: prevalence and effect on outcome (2011) (4)
Use of intravenous iron and risk of anaphylaxis: A multinational observational post‐authorisation safety study in Europe (2021) (4)
UEG Week 2016 Poster Presentations (2016) (4)
Reduced bifidobacteria and increased E. coli in rectal mucosa-associated flora in active inflammatory bowel disease (2002) (4)
Clubbing in Crohn's disease. (1993) (4)
Expression of thiopurine methyltransferase in South Asians (2003) (3)
Does topical aloe vera reduce the severity of trinitrobenzene sulphonic acid (TNBS) colitis in rats (1998) (3)
The effect of sulphasalazine withdrawal on rectal mucosal function and prostaglandin E2 release in inactive ulcerative colitis. (1981) (3)
Clinical Significance of Platelet Size in Inflammatory Bowel Disease? (1997) (3)
Synbiotic therapy for ulcerative colitis (2005) (3)
Predicting relapse in Crohn's disease: a biopsychosocial model (2009) (2)
The Canadian essay (1991) (2)
P335 Thiopurine nonadherence is more common in adolescents than adults with IBD, is associated with psychological distress and impacts on the management and prognosis (2013) (2)
Rising incidence of inflammatory bowel disease in Bangladeshis in East London (2003) (2)
Herbal therapies used by patients for inflammatory bowel disease are antioxidant in vitro (2000) (2)
Small intestinal luminal pH in Crohn's disease: Implications for release of antiinflammatory drugs from pH-dependent capsules (2000) (2)
A prospective study of the incidence and significance of stigmata of recent hemorrhage in ulcer patients without clinical evidence of recent bleeding (1991) (2)
Colitis and Non-Steroidal Anti-Inflammatory Drugs (1988) (2)
Platelet–leucocyte aggregation in IBD (2007) (2)
Successful Use of Adalimumab (Humira) for Crohn's Disease in Pregnancy (2006) (2)
Duodenal ulcer (DU) in H. pylori infected patients: Role of ethnicity, sex, and smoking and neutrophil activation (1995) (2)
Understanding and managing psychological disorders in patients with inflammatory bowel disease: a practical guide (2022) (2)
Systematic review: clostridium difficile and IBD (2011) (2)
The changing world of inflammatory bowel disease: impact of generation, gender and global trends (2010) (2)
Measurement of Absorptive and Secretory Function (1991) (2)
Treatment of anaemia in inflammatory bowel disease: authors’ reply (2006) (2)
Anti-inflammatory effect of N-acetylcysteine (NAC) in a model of colitis (2003) (1)
Colonic Drug Absorption and Metabolism (1994) (1)
FOOD INTOLERANCE, PROSTAGLANDINS, AND IRRITABLE BOWEL SYNDROME (1983) (1)
Eicosanoids in amebiasis. (1990) (1)
Commentary: predictors of severe outcomes associated with Clostridium difficile infection in inflammatory bowel disease patients (2012) (1)
Steroids in Crohn's: are They Obsolete? (2007) (1)
polyposis . compared with familial adenomatous pouch mucosa in ulcerative colitis Increased leukotriene B 4 release from ileal (1)
Are Maintenance Strategies Underused in Crohn's Disease? (2014) (1)
Efficacy and usage of oral iron therapy in inflammatory bowel disease (2001) (1)
Effect of Prostaglandin E2 on Colonic Mucosal Function and Structure in the Rat (1980) (1)
The Impact of Counseling and Other Psychological Treatments on IBD (2009) (1)
Joint pain and joint hypermobility in inflammatory bowel disease (2011) (1)
Trials and Tribulations — Interpreting Clinical Trials in IBD (2007) (1)
Subject Index Vol. 27, Suppl. 1, 2009 (2010) (0)
Ion transport in inflammatory bowel disease. (1981) (0)
How Can we Prevent Tuberculosis (2007) (0)
Subject Index Vol. 13, 2006 (2007) (0)
Leukocytapheresis: Filtering Out the Facts (2007) (0)
gastroduodenal disease . nitroimidazole exposure and east London : relation with previous metronidazole resistance in migrants to High prevalence of Helicobacter pylori (2006) (0)
PTH-010 Rises In both White Cell Count and Crp at Day 3 Predict Failure of Treatment with Metronidazole in C.Difficile Infection (2013) (0)
Contents Vol. 13, 2006 (2007) (0)
Do Endoscopists Give Greater Sedation to Patients Perceived As Anxious (2007) (0)
Complementary therapy in IBD patients: Who uses it and why? (2000) (0)
Centre and periphery (1994) (0)
Colitis (1993) (0)
BDiversion^ Colitis Caused by Clostridium difficile Infection: Report of a Case (2006) (0)
Active bacteria associated with colorectal biopsies (2006) (0)
Benoxaprofen: effect on cutaneous lesions in psoriasis. (1982) (0)
P274 - Hydrocortisone and noradrenaline down-regulate the expression of the constitutively expressed colonic epithelial antibacterial peptides (2009) (0)
Risk factors in the development of C.difficile infection (2012) (0)
Su1321 C. difficile Colonization and Infection Rates Are Now Low in Inflammatory Bowel Disease - A Matched Cohort Study (2015) (0)
The Effect of Disodium Cromoglycate on Rectal Mucosal Histamine Release and Eosinophil Exudation in Active Ulcerative Colitis (1982) (0)
Proceedings of the Pathological Society of Great Britain and Ireland, 167th Meeting. Edinburgh, July 7-9, 1993. Abstracts. (1993) (0)
Pseudohyperkalaemia (1985) (0)
W1264 Does Psychological Counselling Alter the Natural History of Inflammatory Bowel Disease (2008) (0)
APPENDICECTOMY IN ULCERATIVE COLITIS. AUTHOR'S REPLY (1999) (0)
Thin-client distributed computer network in a GI investigation unit — Putting theory into practice (2000) (0)
P034 Psychological Counselling May Improve the Natural History of Inflammatory Bowel Disease (IBD) (2007) (0)
Inflammatory mediators in ulcerative colitis (1991) (0)
PWE-144 Predicting Treatment Failure in C.Difficile Infection: A Prospective Observational Cohort Study (2016) (0)
Manual of gastroenterologic procedures (1988) (0)
Infliximab and Surgery: Health Or Hazard? (2007) (0)
P294 - Control of interleukin-17 production in inflammatory bowel disease (2009) (0)
Platelets in Thrombotic and Non-thrombotic Disorders: Platelets in inflammatory bowel disease (2002) (0)
Complementary and Alternative Therapy ‐the Way Forward Or a Step Back? (2007) (0)
Clostridium Difficile Infection in Patients with Inflammatory Bowel Disease (2012) (0)
Evidence for neuronal hyperplasia and increased VIP and VIP mRNA in the submucosa in inflammatory bowel disease (1993) (0)
Platelet endothelial cell adhesion molecule-1 in uninvolved areas of gut in inflammatory bowel disease (1993) (0)
AssociationofGeneticVariantsinNUDT15WithThiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease (2019) (0)
Thiopurines, but not corticosteroids or 5-ASA, reduce the number of platelet-leucocyte aggregates in patients with inflammatory bowel disease (2003) (0)
Standards for Bacterial Identification by Fluorescence In Situ Hybridization Within Eukaryotic Tissue Using Ribosomal rRNA‐Based Probes: Reply (2006) (0)
Co-localisation of toll-like receptors with signalling molecules IRAK-1 and NF kappa B in colonic biopsies of patients with inflammatory bowel disease (2006) (0)
Reduced VIP binding in human inflammatory bowel disease (1993) (0)
Release of 5-ASA from Asacol appears independent of gut luminal pH in ulcerative colitis (2001) (0)
Crohn's disease inmonozygotic twins (1986) (0)
PTU-087 Poster presentations: an effective way of disseminating research? (2010) (0)
C.difficile infection rate in patients with IBD is falling in line with that of the general population (2015) (0)
Prostaglandins and ulcerative colitis. (1980) (0)
T1028 Poster Presentations: An Effective Way of Disseminating Research? (2010) (0)
14C-PHENYLACETIC OIL AS FAT ABSORPTION TEST (1980) (0)
C.difficile colonisation and infection rates are now low in IBD - a matched cohort study (2015) (0)
Crohn's disease inBangladeshis andEuropeans inBritain: anepidemiological comparison inTowerHamlets (1992) (0)
Proceedings of the Pathological Society of Great Britain and Ireland. London, January 3,4 and 5, 1990. Synopses of papers with microbiological interest. (1990) (0)
Platelet activation may initiate leucocyte-platelet aggregation in inflammatory bowel disease (2001) (0)
48. IBS is Common in IBD: Fact or Fallacy? (2012) (0)
Management of Internal Fistulae (2007) (0)
Relapse ofulcerative proctocolitis during treatment withnon-steroidal anti-inflammatory drugs (1981) (0)
Topics in gastroenterology (1987) (0)
Discussion on impaired expression of peroxisome proliferator-activated receptor beta in ulcerative colitis. (2004) (0)
OC-037 A Perianal Swab-Based PCR Assay for Diagnosing Colonisation by Pathogenic C.difficile (2016) (0)
Effect of inflammation on gut flora diversity in inflammatory bowel disease patients: 16S rDNA sequence analysis (2006) (0)
Profiling rectal mucosal mediator production in ulcerative colitis using a filter paper method: Increased production of interleukin-1β, prostaglandin E2 and thromboxane A2 (1998) (0)
P101 NICOTINE EXERTS ITS ANTI-INFLAMMATORY EFFECTS ON COLONOCYTES VIA INHIBITION OF ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTOR, NF-êB (2008) (0)
Use of Rectal Dialysis for Assessment of Mucosal Prostaglandin Production in Man (1980) (0)
PTU-045 Smokers with inflammatory bowel disease have low nicotine dependence (2010) (0)
Short fiction : an introductory anthology (1992) (0)
Patients' understanding of colonoscopy risk is suboptimal. (2004) (0)
P299 - The stress mediators adenosine and hydrocortisone impair epithelial wound healing in vitro (2009) (0)
Profiling the bacterial community associated with the rectal mucosa in inflammatory bowel disease (IBD) using 165 rDNA denaturing gradient gel electrophoresis (2003) (0)
C. difficile colonisation or infection does not appear to increase the risk of a diagnosis of IBD in the subsequent 2 years (2015) (0)
Psychological Stress: Something to Worry About? (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David S. Rampton?

David S. Rampton is affiliated with the following schools:

Queen Mary University of London